Log in
NYSE:ANTM

Anthem Stock Forecast, Price & News

$312.80
+3.75 (+1.21 %)
(As of 11/27/2020 12:00 AM ET)
Add
Compare
Today's Range
$308.24
Now: $312.80
$313.54
50-Day Range
$272.80
MA: $305.25
$333.15
52-Week Range
$171.03
Now: $312.80
$338.20
Volume533,263 shs
Average Volume1.61 million shs
Market Capitalization$77.79 billion
P/E Ratio16.17
Dividend Yield1.23%
Beta0.97
Anthem, Inc., through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional indemnity plans and other hybrid plans, such as consumer-driven health plans; and hospital only and limited benefit products. The company also provides a range of managed care services to self-funded customers, including claims processing, underwriting, stop loss insurance, actuarial services, provider network access, medical cost management, disease management, wellness programs, and other administrative services. In addition, it offers an array of specialty and other insurance products and services, such as dental, vision, life and disability insurance benefits, radiology benefit management, and analytics-driven personal health care guidance; and Medicare administrative services. Further, the company provides services to the federal government in connection with the Federal Employee Program; and operates as a licensee of the Blue Cross and Blue Shield Association. As of December 31, 2019, it served 41 million medical members through its affiliated health plans. Anthem, Inc. has a strategic relationship with Quest Diagnostics Incorporated to develop various outcomes-based programs for enhanced health care experience for consumers and providers. The company was formerly known as WellPoint, Inc. and changed its name to Anthem, Inc. in December 2014. Anthem, Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Read More
Anthem logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.4Community Rank: 2.5Dividend Strength: 1.7Insider Behavior: 1.7Valuation: 3.1 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.07 out of 5 stars


Industry, Sector and Symbol

Industry Hospital & medical service plans
Sub-IndustryManaged Health Care
SectorMedical
CUSIP94973V10
Phone800-331-1476
Employees70,600

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$104.21 billion
Cash Flow$24.32 per share
Book Value$136.39 per share

Profitability

Net Income$4.81 billion

Miscellaneous

Market Cap$77.79 billion
Next Earnings Date2/3/2021 (Estimated)
OptionableOptionable
$312.80
+3.75 (+1.21 %)
(As of 11/27/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ANTM News and Ratings via Email

Sign-up to receive the latest news and ratings for ANTM and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Anthem (NYSE:ANTM) Frequently Asked Questions

How has Anthem's stock price been impacted by Coronavirus (COVID-19)?

Anthem's stock was trading at $281.69 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, ANTM shares have increased by 11.0% and is now trading at $312.80.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Anthem?

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Anthem in the last year. There are currently 4 hold ratings and 12 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Anthem
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Anthem?

Wall Street analysts have given Anthem a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Anthem wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Anthem's next earnings date?

Anthem is scheduled to release its next quarterly earnings announcement on Wednesday, February 3rd 2021.
View our earnings forecast for Anthem
.

How were Anthem's earnings last quarter?

Anthem, Inc. (NYSE:ANTM) posted its quarterly earnings data on Wednesday, October, 28th. The company reported $4.20 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $4.04 by $0.16. The business had revenue of $30.65 billion for the quarter, compared to analyst estimates of $29.81 billion. Anthem had a return on equity of 18.45% and a net margin of 4.22%.
View Anthem's earnings history
.

How often does Anthem pay dividends? What is the dividend yield for Anthem?

Anthem announced a quarterly dividend on Thursday, October 29th. Stockholders of record on Monday, December 7th will be paid a dividend of $0.95 per share on Tuesday, December 22nd. This represents a $3.80 dividend on an annualized basis and a dividend yield of 1.21%. The ex-dividend date is Friday, December 4th.
View Anthem's dividend history
.

What guidance has Anthem issued on next quarter's earnings?

Anthem issued an update on its FY 2020 Pre-Market earnings guidance on Wednesday, October, 28th. The company provided EPS guidance of 22.30 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $22.47.

What price target have analysts set for ANTM?

16 Wall Street analysts have issued 12-month price targets for Anthem's shares. Their forecasts range from $281.00 to $423.00. On average, they expect Anthem's stock price to reach $343.94 in the next twelve months. This suggests a possible upside of 10.0% from the stock's current price.
View analysts' price targets for Anthem
.

Who are some of Anthem's key competitors?

What other stocks do shareholders of Anthem own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Anthem investors own include UnitedHealth Group (UNH), NVIDIA (NVDA), Intel (INTC), The Walt Disney (DIS), Visa (V), Johnson & Johnson (JNJ), Alibaba Group (BABA), AbbVie (ABBV), The Home Depot (HD) and The Boeing (BA).

Who are Anthem's key executives?

Anthem's management team includes the following people:
  • Ms. Gail Koziara Boudreaux, Pres, CEO & Director (Age 59, Pay $4.32M)
  • Mr. John Edward Gallina, Exec. VP & CFO (Age 60, Pay $1.84M)
  • Ms. Gloria Marie McCarthy, Exec. VP and Chief Admin. Officer (Age 67, Pay $1.86M)
  • Mr. Peter David Haytaian, Exec. VP and Pres of Commercial & Specialty Bus. Division (Age 50, Pay $1.83M)
  • Ms. Felicia Farr Norwood, Exec. VP & Pres of Gov. Bus. Division (Age 60, Pay $1.57M)
  • Mr. Scott Wayne Anglin, SVP, Treasurer & Chief Investment Officer
  • Mr. Ronald William Penczek, Sr. VP, Controller & Chief Accounting Officer (Age 55)
  • Mr. Thomas H. Miller, Sr. VP & Chief Information Officer (Age 62)
  • Chris Rigg, VP of Investor Relations
  • Mr. Thomas Casimir Zielinski Jr., Exec. VP & Gen. Counsel (Age 69)

What is Anthem's stock symbol?

Anthem trades on the New York Stock Exchange (NYSE) under the ticker symbol "ANTM."

Who are Anthem's major shareholders?

Anthem's stock is owned by a variety of institutional and retail investors. Top institutional investors include State Street Corp (4.39%), Orbis Allan Gray Ltd (1.40%), Sanders Capital LLC (1.23%), Boston Partners (0.89%), Nuveen Asset Management LLC (0.80%) and UBS Asset Management Americas Inc. (0.70%). Company insiders that own Anthem stock include Gail Boudreaux, Gloria M Mccarthy, Julie A Hill, Peter D Haytaian, Ramiro G Peru, Robert L Dixon Jr, Ronald W Penczek and Thomas C Zielinski.
View institutional ownership trends for Anthem
.

Which institutional investors are selling Anthem stock?

ANTM stock was sold by a variety of institutional investors in the last quarter, including Nuveen Asset Management LLC, First Hawaiian Bank, State Street Corp, Artemis Investment Management LLP, CI Investments Inc., Assenagon Asset Management S.A., Acadian Asset Management LLC, and Charles Schwab Investment Management Inc.. Company insiders that have sold Anthem company stock in the last year include Gloria M Mccarthy, Julie A Hill, Peter D Haytaian, Robert L Dixon Jr, and Thomas C Zielinski.
View insider buying and selling activity for Anthem
.

Which institutional investors are buying Anthem stock?

ANTM stock was bought by a variety of institutional investors in the last quarter, including Voloridge Investment Management LLC, CIBC Private Wealth Group LLC, Sanders Capital LLC, BNP PARIBAS ASSET MANAGEMENT Holding S.A., AQR Capital Management LLC, Orbis Allan Gray Ltd, KBC Group NV, and Great West Life Assurance Co. Can.
View insider buying and selling activity for Anthem
.

How do I buy shares of Anthem?

Shares of ANTM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Anthem's stock price today?

One share of ANTM stock can currently be purchased for approximately $312.80.

How big of a company is Anthem?

Anthem has a market capitalization of $77.79 billion and generates $104.21 billion in revenue each year. The company earns $4.81 billion in net income (profit) each year or $19.44 on an earnings per share basis. Anthem employs 70,600 workers across the globe.

What is Anthem's official website?

The official website for Anthem is www.antheminc.com.

How can I contact Anthem?

Anthem's mailing address is 220 VIRGINIA AVENUE, INDIANAPOLIS IN, 46204. The company can be reached via phone at 800-331-1476 or via email at [email protected]

This page was last updated on 11/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.